Indication
Broad Solid Tumor
1 clinical trial
3 products
Product
BMS-986207Product
NivolumabProduct
IpilimumabClinical trial
Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid TumorsStatus: Completed, Estimated PCD: 2024-01-25